FindTrial
Sign In

Prospective Study to Estimate Improvement of Dyspeptic Symptoms Post H. Pylori Therapy

Observational Endoscopic Study of Empirical Treatment of H. Pylori Based on Endoscopic Findings - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087777
Enrollment
150
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

DR FRAZER RODRIGUES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18yrs Patients with dyspeptic symptoms Patients willing to undergo UGI scopy and receive H pylori eradication therapy Patient Not on any H Pylori Therapy previously Started Patient Not having Noted Histopathological Findings Positive in Stomach on Endoscopy

Exclusion criteria

Exclusion criteria: Age less than 18yrs Patients not willing for UGI scopy Normal UGI scopy Suspected growth or Malignancy on UGI scopy Not compliant with the treatment Lost to Follow Up Patient on Medications causing Gastritis

Design outcomes

Primary

MeasureTime frame
To estimate the improvement in pain in patients receiving H. pylori eradication therapy following endoscopyTimepoint: 2 weeks and 4 weeks from UGI Scopy Date—

Secondary

MeasureTime frame
To Estimate the Complete Relief of Symptoms in patients post receiving H. pylori eradication therapy for 14 Days following EndoscopyTimepoint: 21 Days & 30 Days from UGI Scopy—

Countries

India

Contacts

Public ContactFrazer C S Rodrigues

Department of General Surgery, Goa Medical College

rodriguesjude@hotmail.com9422453261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026